Latest Tuberculosis treatment Stories
Immune Network Ltd. (IMMFF), announces the completion of a Phase II trial of a once-daily M. vaccae pill (V7) conducted by Immunitor in Ukraine.
In 2010 the World Health Organization (WHO) estimated there were 290,000 cases of multi-drug resistant tuberculosis globally. Now a new medication attempts to slash those numbers.
A joint Innovation Summit seeks to find solutions for identified barriers to treating tuberculosis. Boston, MA (PRWEB) May 17, 2012 Leading global public
Today, the European Respiratory Society (ERS) and the European Centre for Disease Prevention and Control (ECDC) publish their jointly developed European Union Standards for Tuberculosis Care (ESTC).
A two-drug combination is one of the most promising advances in decades for the treatment of tuberculosis (TB) — a disease that kills 2 million people annually — a scientist reported today at the 243 National Meeting & Exposition of the American Chemical Society (ACS).
Looking at the current state of TB knowlege and new cases we have come a long way, but dont think that this is over. Cleveland, OH (PRWEB) March 24, 2012
The management of tuberculosis cases in the European Union (EU) is not meeting international standards, according to new research.
Tuberculosis patients may receive treatments in the future according to what version they have of a single 'Goldilocks' gene.
- A handkerchief.
- In general, any miraculous portrait of Christ.